Seagen Inc. (NASDAQ: SGEN)
You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Seagen Inc. Returns vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Seagen Inc. Company Info
Seagen is a biotechnology company that develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases.
News & Analysis
The billionaire investor is a big believer in betting on America.
It's probably better to think about whether to buy more shares.
Merck is thinking about whether it's an appealing acquisition target.
Buying these stocks on the dip could result in big returns for investors.
These stocks are already down more than 20% this year.
Investors aren't happy about disappointing forward guidance.
And doing so wouldn't have involved gambling with your portfolio, either.
These companies just keep on growing.
Motley Fool Returns
Market-beating stocks from our award-winning analyst team.
Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/24/2022.
Discounted offers are only available to new members. Stock Advisor list price is $199 per year.
Calculated by Time-Weighted Return since 2002. Volatility profiles based on trailing-three-year calculations of the standard deviation of service investment returns.
Valuation
Earnings Transcripts
SGEN earnings call for the period ending June 30, 2022.
SGEN earnings call for the period ending March 31, 2022.
SGEN earnings call for the period ending December 31, 2021.
SGEN earnings call for the period ending September 30, 2021.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.